SSA timeline
Every SSA batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| SSA-2605-G6892 | Mazdutide | 07 May 2026 | 2026-Q2 | 2 | 98.92 | 0.09 | 98.87 | -0.05 | |
| SSA-2604-L7739 | Semax | 17 Apr 2026 | 2026-Q2 | 2 | 98.55 | 0.31 | 98.86 | +0.31 | |
| SSA-2604-V7731 | GHK-Cu | 10 Apr 2026 | 2026-Q2 | 13 | 98.37 | 1.50 | 98.18 | -0.19 | |
| SSA-2603-C7061 | Enclomiphene citrate | 04 Mar 2026 | 2026-Q2 | 1 | 98.48 | n<2 | 98.66 | +0.18 | |
| SSA-2601-N6863 | BPC-157 | 09 Jan 2026 | 2026-Q2 | 15 | 98.03 | 0.95 | 97.50 | -0.53 | |
| SSA-2512-C6843 | CJC-1295 with DAC | 17 Dec 2025 | 2026-Q1 | 5 | 98.41 | 0.80 | 98.57 | +0.16 | |
| SSA-2511-N7226 | Tirzepatide | 04 Nov 2025 | 2026-Q2 | 3 | 98.27 | 0.57 | 98.14 | -0.13 | |
| SSA-2510-E6613 | Retatrutide | 26 Oct 2025 | 2025-Q4 | 11 | 97.36 | 1.08 | 97.50 | +0.14 | |
| SSA-2509-J7377 | Semaglutide | 10 Sep 2025 | 2025-Q4 | 7 | 97.81 | 1.00 | 97.09 | -0.72 | |
| SSA-2509-Y7224 | IGF-1 DES (1-3) | 08 Sep 2025 | 2025-Q4 | 3 | 97.77 | 0.62 | 98.04 | +0.27 | |
| SSA-2508-P6927 | Humanin (HNG) | 26 Aug 2025 | 2025-Q3 | 4 | 99.06 | 0.58 | 99.22 | +0.16 | |
| SSA-2508-P6164 | Tirzepatide | 25 Aug 2025 | 2026-Q1 | 5 | 97.87 | 1.32 | 97.83 | -0.04 | |
| SSA-2508-B6436 | Vilon | 18 Aug 2025 | 2025-Q3 | 3 | 99.15 | 0.13 | 99.51 | +0.36 | |
| SSA-2508-N7334 | Retatrutide | 12 Aug 2025 | 2025-Q3 | 4 | 98.00 | 0.40 | 97.83 | -0.17 | |
| SSA-2508-Y7005 | Semaglutide | 09 Aug 2025 | 2025-Q3 | 3 | 98.61 | 0.55 | 98.77 | +0.16 | |
| SSA-2507-W7449 | Retatrutide | 14 Jul 2025 | 2025-Q3 | 2 | 98.13 | 0.97 | 98.52 | +0.39 | |
| SSA-2506-X6141 | L-Glutathione (reduced) | 05 Jun 2025 | 2025-Q3 | 1 | 99.35 | n<2 | 99.90 | +0.55 | |
| SSA-2505-D7550 | GHRP-2 | 24 May 2025 | 2025-Q2 | 2 | 99.12 | 0.19 | 99.27 | +0.15 | |
| SSA-2505-J7334 | BPC-157 | 13 May 2025 | 2025-Q3 | 8 | 98.64 | 0.84 | 98.40 | -0.24 | SHARED BULK |
| SSA-2505-U7007 | PEG-MGF | 08 May 2025 | 2025-Q4 | 8 | 96.05 | 0.95 | 95.78 | -0.27 | |
| SSA-2504-T7926 | L-Carnosine | 01 Apr 2025 | 2025-Q2 | 3 | 98.95 | 0.50 | 98.56 | -0.39 | |
| SSA-2502-D7226 | Tirzepatide | 11 Feb 2025 | 2025-Q3 | 13 | 97.94 | 1.84 | 97.50 | -0.44 | |
| SSA-2502-U6907 | Semaglutide | 10 Feb 2025 | 2025-Q3 | 12 | 97.99 | 0.57 | 98.37 | +0.38 | |
| SSA-2501-N6328 | Melanotan II | 19 Jan 2025 | 2025-Q1 | 1 | 98.55 | n<2 | 98.55 | 0.00 | |
| SSA-2501-M6154 | MOTS-c | 15 Jan 2025 | 2025-Q1 | 12 | 98.10 | 0.94 | 98.78 | +0.68 | |
| SSA-2501-N6781 | 5-Amino-1MQ | 04 Jan 2025 | 2025-Q2 | 2 | 99.40 | 0.03 | 99.45 | +0.05 | |
| SSA-2410-G6492 | Semax | 12 Oct 2024 | 2024-Q4 | 10 | 98.72 | 1.39 | 98.73 | +0.01 | |
| SSA-2409-X7161 | Sermorelin | 10 Sep 2024 | 2025-Q1 | 6 | 98.51 | 0.67 | 98.71 | +0.20 | |
| SSA-2408-F7321 | Glucagon | 27 Aug 2024 | 2024-Q3 | 1 | 98.53 | n<2 | 98.22 | -0.31 | |
| SSA-2408-G7111 | SS-31 (Elamipretide) | 02 Aug 2024 | 2024-Q3 | 14 | 97.97 | 1.59 | 98.41 | +0.44 | |
| SSA-2407-L7018 | Mazdutide | 09 Jul 2024 | 2024-Q4 | 1 | 96.98 | n<2 | 96.59 | -0.39 | |
| SSA-2407-L6364 | Thymosin α1 | 05 Jul 2024 | 2024-Q3 | 6 | 98.39 | 0.69 | 98.50 | +0.11 | |
| SSA-2406-H7589 | TB-500 | 01 Jun 2024 | 2024-Q4 | 12 | 98.54 | 1.17 | 98.93 | +0.39 | |
| SSA-2405-G6509 | Retatrutide | 26 May 2024 | 2024-Q3 | 3 | 97.97 | 1.35 | 98.32 | +0.35 | |
| SSA-2404-U8057 | Ipamorelin | 09 Apr 2024 | 2024-Q3 | 1 | 98.05 | n<2 | 98.03 | -0.02 | |
| SSA-2403-F6772 | IGF-1 DES (1-3) | 28 Mar 2024 | 2024-Q2 | 11 | 99.19 | 1.20 | 99.30 | +0.11 | |
| SSA-2403-B6931 | Semaglutide | 18 Mar 2024 | 2024-Q2 | 1 | 99.12 | n<2 | 99.18 | +0.06 | |
| SSA-2403-F6498 | PT-141 (Bremelanotide) | 14 Mar 2024 | 2024-Q3 | 4 | 98.65 | 0.36 | 98.68 | +0.03 | |
| SSA-2403-V6369 | LL-37 | 12 Mar 2024 | 2024-Q2 | 4 | 98.16 | 0.44 | 98.12 | -0.04 |